John L. Zabriskie
Plus aucun poste en cours
Profil
John L.
Zabriskie was the founder of Puretech Health LLC (founded in 2000) and Protein Forest, Inc. (founded in 2002), where he held the title of Senior Partner and Director, respectively.
He held various former positions, including President & Chief Executive Officer at Pharmacia & Upjohn, Inc. (1995-1997), Chairman & Chief Executive Officer at The Upjohn Co., Chairman, President & Chief Executive Officer at NEN Life Sciences, Inc., Chairman, President & Chief Executive Officer at NEN Life Sciences Products, Inc. (1997-1999), and Chairman at MacroChem Corp.
(2000-2008).
He also served as an Independent Director at Kellanova (1995-2013), Array BioPharma, Inc. (2001-2013), Momenta Pharmaceuticals, Inc., Mersana Therapeutics, Inc., and Cellicon Biotechnologies, Inc. He was a Director at Biosource International, Inc., ARCA biopharma, Inc. (2005-2009), and Harlan Sprague Dawley, Inc. He was an Advisory Committee Member at Genstar Capital Management LLC and President at Lansing Brown Investments LLC.
Dr. Zabriskie received a doctorate degree from the University of Rochester in 1965, an undergraduate degree from Dartmouth College in 1961, and an undergraduate degree from Cornell University.
Anciens postes connus de John L. Zabriskie
| Sociétés | Poste | Fin |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 23/12/2013 |
| KELLANOVA | Directeur/Membre du Conseil | 19/11/2013 |
| ARCA BIOPHARMA, INC. | Directeur/Membre du Conseil | 19/11/2013 |
Harlan Sprague Dawley, Inc.
 Harlan Sprague Dawley, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Sprague Dawley, Inc. provides preclinical research tools and services. It also develops research in the pharmaceutical, biotechnology, agrochemical, industrial chemical and food industries. The company supplies laboratory animals and laboratory animal diets. The firm was founded in 1931 by Howard P. Harlan and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | 30/09/2010 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Directeur/Membre du Conseil | 27/01/2009 |
Formation de John L. Zabriskie
| Rochester Christian University | Doctorate Degree |
| Dartmouth College | Undergraduate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| KELLANOVA | Consumer Non-Durables |
| ARCA BIOPHARMA, INC. | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Biosource International, Inc.
 Biosource International, Inc. Medical SpecialtiesHealth Technology BioSource International, Inc. manufactures, develops and distributes biomedical research products. Its products include assay test kits, clinical diagnostic kits, bioactive proteins, antibodies, bioactive peptides, oligonucleotides and serum. The company is headquartered in Camarillo, CA. | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Genstar Capital Management LLC
 Genstar Capital Management LLC Investment ManagersFinance Genstar Capital Management LLC is a private equity firm founded in 1988 by Dennis H. Chookaszian. The firm is headquartered in San Francisco., California. | Finance |
| NEN Life Sciences, Inc. | Health Technology |
Harlan Sprague Dawley, Inc.
Harlan Sprague Dawley, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Sprague Dawley, Inc. provides preclinical research tools and services. It also develops research in the pharmaceutical, biotechnology, agrochemical, industrial chemical and food industries. The company supplies laboratory animals and laboratory animal diets. The firm was founded in 1931 by Howard P. Harlan and is headquartered in Indianapolis, IN. | Commercial Services |
| Pharmacia & Upjohn, Inc. | Health Technology |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Health Technology |
Protein Forest, Inc.
 Protein Forest, Inc. Packaged SoftwareTechnology Services Protein Forest, Inc., a privately held company founded in 2002 and is located in Lexington, MA, is a developer and manufacturer of state-of-the-art sample fractionation technology, products, and data analysis software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world. | Technology Services |
Lansing Brown Investments LLC
 Lansing Brown Investments LLC Investment ManagersFinance Founded in 2001, Lansing Brown Investments LLC is a private equity firm located in Boston | Finance |
NEN Life Sciences Products, Inc.
 NEN Life Sciences Products, Inc. Chemicals: Major DiversifiedProcess Industries Part of Revvity, Inc., NEN Life Sciences Products, Inc. is an American company that makes specialty biochemicals. The company is based in MA. NEN Life Sciences Products was acquired by Revvity, Inc. on July 31, 2000 for $400 million. | Process Industries |
| The Upjohn Co. | Health Technology |
Cellicon Biotechnologies, Inc.
 Cellicon Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Cellicon Biotechnologies, Inc. develops pharmaceutical products. It offers technologies for decoding the protein pathway for the cure of human diseases such as diabetes, arthritis, and cancer. The company was founded in 2002 by Timothy Gardner and is headquartered in Boston, MA | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
